Skip to main content
Signal8

BIOREGENX, INC. (BRGX)

BioRegenx, Inc. develops, manufactures, and sells medical test equipment, science-based nutritional products, and AI-driven health monitoring technologies. Its products include the GlycoCheck system for microvascular health assessment, the Endocalyx Pro dietary supplement, and the DocSun AI engine for contactless vital sign monitoring. The company focuses on regenerative biotherapeutics, anti-aging, and non-invasive medical and wellness devices.

Sector: Services-Computer Programming, Data Processing, Etc.

Industry: Medical - Instruments & Supplies

BioRegenx, Inc. logo

BioRegenx, Inc.

OTC:BRGXTechnology
$0.0002
Mkt Cap$194K
Float322.23M
O/S971.58M
Inst Own-
SI0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$1.85M
Net Income-$1.54M
Total Assets$411K
Free Cash Flow$30K
Debt & Equity
Total Debt$2.21M
Total Equity-$4.54M
Preferred Stock$4
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in BRGX's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$411K
Liabilities$4.95M
Accounts Receivable$40K
Accounts Payable$616K
Inventory$107K
PP&E (Net)$160K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2015FY 2014FY 2012FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312015-12-312014-12-312012-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue$1.85M$2.34M$22K$42K$199K$404K$478K$258K$269K$344K$191K$8.01M$0$0$0$0$55K$45K
YoY Growth-20.7%10420.2%-47.2%-78.8%-50.9%-15.4%85.4%-4.0%-21.9%79.5%-97.6%-----23.1%-
Cost of Revenue$351K$682K$6K$6K$554$45K$213K$1K$0$0$0$7.05M$0$0$0$0$0$0
Gross Profit$1.5M$1.66M$16K$36K$198K$359K$265K$257K$0$0$0$956K$0$0$0$0$55K$45K
Gross Margin81.1%70.9%73.3%85.9%99.7%88.9%55.4%99.5%---11.9%----100.0%100.0%
Research and Development$0$0$0$0$1.18M$318K$0$0$0$0$0$0$0$0$0$0$0$0
Selling, General, and Administrative$2.01M$5.85M$107K$62K$155K$394K$475K$298K$343K$332K$226K$2.7M$224K$454K$294K$0$100K$16K
Other$16K$17.89M$19K$53K-$972K-$136K$0$6K$0$0$0-$10K$0$0$0-$181K$0$0
Total Operating Expenses$2.02M$23.74M$126K$115K$363K$575K$475K$304K$343K$332K$226K$2.69M$224K$454K$294K-$181K$100K$16K
Operating Income (EBIT)-$519K-$22.76M-$110K-$78K-$165K-$216K-$210K-$47K-$74K$12K-$35K-$1.74M-$224K-$454K-$294K-$181K-$45K$29K
Operating Margin-28.0%-972.8%-494.5%-185.7%-83.1%-53.4%-43.9%-18.3%-27.6%3.5%-18.2%-21.8%-----81.4%64.5%
Interest Expense-$300K$291K$8K$0$0$0$0$0$7K$3K$982$0$0$0$0$0$0$0
Interest Income$0$0$0$0$0$0$0$0$0$0$0$11K$0$0$0$0$0$0
Other Income (Expense)-$1.02M-$291K-$462K$0$68K-$58K$1K$5K-$7K-$3K-$982-$1K$0$0$0$0$0$0
Income Before Tax (EBT)-$1.54M-$23.05M-$571K-$78K-$97K-$274K-$208K-$47K-$81K$9K-$36K-$1.75M$0$0$0$0$0$0
Income Tax Expense$0$0$0$0$0$58K$0$0$0$0$0$0$449K$907K$294K$181K$45K$72K
Net Income-$1.54M-$23.05M-$571K-$78K-$97K-$332K-$208K-$47K-$81K$9K-$36K-$1.75M-$224K-$454K-$294K-$181K-$45K-$72K
Net Income Margin-83.2%-985.2%-2567.1%-185.7%-48.8%-82.1%-43.5%-18.3%-30.3%2.7%-18.7%-21.8%-----81.4%-162.0%
Supplementary Data
EPS-0.00-0.02-0.00-0.00-0.00-0.00-0.000.00-0.000.000.00-0.53-12.55-64.36-1554.82-5850.90-44771.00-72381.00
Diluted EPS-0.00-0.02-0.00-0.00-0.00-0.00-0.000.00-0.000.000.00-0.53-12.55-64.36-1554.82-5850.90-44771.00-72381.00
Weighted Average OS959.71M939.51M276.37M269.75M269.75M267.96M265.66M01.60B1.60B1.63B3.29M17.87M7.05M189,00031,00000
EBITDA-$444K-$22.76M-$558K-$72K-$161K-$152K-$204K-$41K-$74K$12K-$35K-$419-$224K-$454K-$294K-$181K-$45K$29K
EBITDA Margin-23.9%-972.8%-2509.7%-171.7%-81.1%-37.6%-42.7%-16.0%-27.6%3.5%-18.2%-0.0%-----81.4%64.5%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2015FY 2014FY 2012FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312015-12-312014-12-312012-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Assets
Current Assets
Cash and Cash Equivalents$69K$58K$125K$676$24K$94K$38K$3K$7K$2K$242K$45K$26$144$9K$161$6K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$69K$58K$125K$676$24K$94K$38K$3K$7K$2K$242K$45K$26$144$9K$161$6K
Accounts Receivable$40K$15K$0$0$985$971$0$0$0$0$53K$0$0$0$0$430K$64K
Inventory$107K$111K$0$0$653K$850K$0$0$0$0$161K$0$0$0$0$0$0
Other Current Assets$35K$123K$0$0$349K$0$0-$119$0$138$39K$0$0$0$0$0$0
Total Current Assets$251K$308K$653K$676$24K$95K$38K$3K$7K$2K$494K$45K$26$144$9K$430K$70K
Long-Term Assets
Property, Plant & Equipment Net$160K$201K$0$0$23K$0$0$0$0$0$239K$0$0$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$2.64M$0$0$0$0$0$0
Intangible Assets$0$0$32K$37K$43K$48K$54K$59K$0$0$16K$0$0$0$0$0$0
Long-Term Investments$0$0$100$21K$60K$225K$0$9K$9K$9K$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$80K$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0-$103K$0$0-$9K$87K$87K$0$75K$0$0$0$0$0
Total Long-Term Assets$160K$201K$32K$58K$103K$273K$54K$59K$95K$95K$2.89M$75K$0$0$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$411K$509K$32K$59K$128K$368K$92K$62K$102K$98K$3.61M$119K$26$144$9K$430K$70K
Liabilities
Current Liabilities
Accounts Payable$616K$427K$28K$20K$12K$33K$71K$13K$38K$47K$609K$19K$118K$65K$29K$14K$0
Short-Term Debt$2.03M$1.91M$225K$45K$2K$1K-$7K$0$0$0$0$25K$35K$35K$35K$366K$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$60K$197K-$28K-$20K-$12K$7K$7K$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$0$1.1M$28K$20K$12K$0$7K$76K$73K$190K$5.26M$0$0$0$6K$0$0
Total Current Liabilities$4.07M$3.63M$254K$65K$14K$42K$78K$76K$73K$190K$5.26M$44K$153$100$70K$380K$0
Long-Term Liabilities
Long-Term Debt$182K$255K$150K$196K$198K$149K$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$700K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$882K$255K$150K$196K$198K$149K$0$0$0$0$0$0$0$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$4.95M$3.89M$254K$261K$212K$190K$78K$76K$73K$190K$5.26M$44K$153K$100K$70K$380K$0
Stockholders' Equity
Preferred Stock$4$4$10K$10K$10K$10K$10K$10K$0$0$0$0$0$0$0$0$0
Common Stock$969K$1.23M$277K$270K$270K$270K$266K$264K$238K$127K$10K$96K$23K$3K$72K$34K$10K
Retained Earnings-$37.12M-$35.57M-$3.51M-$2.92M-$2.8M-$2.54M-$2.45M-$2.25M-$2.14M-$2.15M-$1.74M-$1.28M-$1.06M-$604K-$310K-$128K-$84K
Comprehensive Income & Other$0$2K-$5K$0-$10K$215K-$266K$0$0$0$0-$3K$0$0$0$0$0
Other Stockholders' Equity$31.61M$30.97M$3.01M$2.45M$2.45M$2.45M$2.2M$2.03M$1.93M$1.93M$84K$1.26M$881K$501K$177K$144K$143K
Total Equity-$4.54M-$3.38M-$222K-$202K-$84K$178K$14K$45K$29K-$92K-$1.65M$75K-$153K-$100K-$61K$50K$70K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$411K$509K$32K$59K$128K$368K$92K$121K$102K$98K$3.61M$119K$26$144$9K$430K$70K
Supplementary Data
Total Debt$2.21M$2.16M$225K$241K$200K$150K$0$0$0$0$0$25K$35K$35K$35K$366K$0
Net Debt$2.15M$2.11M$225K$240K$176K$56K-$38K-$3K-$7K-$2K$0-$20K$35$35$26K$366K-$6K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2014FY 2012FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312014-12-312012-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Operating Activities
Net Income-$1.54M-$22.28M-$15K-$117K-$97K-$332K-$208K-$47K-$36K-$1.74M-$224K-$454K-$294K-$181K-$45K-$72K
Depreciation & Amortization$75K$2.22M$5K$6K$4K$6K$6K$6K$0$1.74M$0$0$0$0$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable-$25K$90K$0$0$971-$971$98K$0$0$0$0$0$0$0$0$0
  Inventory$4K$106K$0$0$263K$0-$98K$0$0$0$0$0$0$0$0$0
  Accounts Payable$322K$186K$9K$8K-$21K-$38K$58K$0$399$0$0$0$0$0$0$0
  Other Working Capital$76K$0$0$0-$270K$500$2K$0$60K$0$0$0$0$0$0$0
Total Working Capital Change$378K$529K$9K$8K-$27K-$38K$60K$0$60K$0-$99K$54K$30K$35K$14K$0
Other Non-Cash Items$1.13M$19.74M-$11K$39K$165K$270K$0-$15K$0$1K$273K$400K$255K$120K$25K$25K
Net Cash from Operating$39K-$324K-$13K-$65K-$120K-$94K-$142K-$57K$24K$0-$51K-$118-$9K-$26K-$5K-$47K
Investing Activities
Capital Expenditures-$9K-$189K$0$0-$32K$0$0$0-$80K$0-$75K$0$0$0$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities-$50K$1K$0$0$0$0$0$0$37K$0$0$0$0$0$0-$64K
Net Cash from Investing-$59K-$188K$0$0-$32K$0$0$0-$44K$0-$75K$0$0$0$0-$64K
Financing Activities
Debt Repaid-$33K---------------
Common Stock Issuance$0$10.66M$82K$0$0$248K$177K$0$20K$0$180K$0$0$0$0$104K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$442K$13K$41K$50K$150K$177K$59K$20K$0$170K$0$0$35K$0$113K
Net Cash from Financing$33K$442K$13K$41K$50K$150K$177K$59K$20K$0$170K$0$0$35K$0$113K
Forex Effect-$2K$0$0$0$32K$0$0$0$0$0$0$0$0$0$0-$40
Net Change in Cash$11K-$67K-$676-$24K-$70K$56K$35K$3K$0$0$45K-$118-$9K$9K-$5K$2K
Supplementary Data
Operating Cash Flow$39K-$324K-$13K-$65K-$120K-$94K-$142K-$57K$24K$0-$51K-$118-$9K-$26K-$5K-$47K
Capital Expenditure-$9K-$189K$0$0-$32K$0$0$0-$80K$0-$75K$0$0$0$0$0
Free Cash Flow$30K-$514K-$13K-$65K-$151K-$94K-$142K-$57K$24K$0-$125K-$118-$9K-$26K-$5K-$47K
Cash at Beginning$58K$125K$676$24K$94K$38K$3K$0$0$0$26$144$9K$161$6K$4K
Cash at End$69K$58K$125K$676$24K$94K$38K$3K$2K$0$45K$26$144$9K$161$6K